Whalegun
Home

Acadia Pharmaceuticals ACAD paid The Conafay Group $10K for lobbying in Q4 2023 · Medical, Medicare

Trade details

Type
Lobbying report
Amount
$10,000
Quarter
Q4 2023
Stock
Acadia Pharmaceuticals ACAD
Client
Acadia Pharmaceuticals
Reported
24/01/22

Up 0.0% from last quarter

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/01~24/01/30

Acadia Pharmaceuticals's other lobbying reports